MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Enzymotec Ltd Company Profile (NASDAQ:ENZY)

Consensus Ratings for Enzymotec Ltd (NASDAQ:ENZY) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $11.00 (17.90% upside)

Analysts' Ratings History for Enzymotec Ltd (NASDAQ:ENZY)
Show:
DateFirmActionRatingPrice TargetActions
11/11/2015Canaccord GenuityReiterated RatingBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2015Canaccord GenuityReiterated RatingBuy$10.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2015Wells FargoUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015Jefferies GroupBoost Price TargetHold$9.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2015Jefferies GroupBoost Price TargetHold$7.50 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Canaccord GenuitySet Price TargetBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015Canaccord GenuityReiterated RatingBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2015Canaccord GenuityReiterated RatingBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2014Jefferies GroupReiterated RatingHold$10.00 -> $7.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2014Jefferies GroupLower Price Target$14.50 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2014Wells FargoDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2014Jefferies GroupLower Price TargetHold$25.00 -> $14.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2014WedbushLower Price Target$33.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2014Canaccord GenuityReiterated RatingBuy$33.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/11/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha